Mechanical loading enhances the anabolic effects of intermittent parathyroid hormone (1-34) on trabecular and cortical bone in mice

Bone

Volumn 43, Issue 2, 2008, Pages 238-248

  Sugiyama, Toshihiro ^a   Saxon, Leanne K ^a   Zaman, Gul ^a   Moustafa, Alaa ^a   Sunters, Andrew ^a   Price, Joanna S ^a   Lanyon, Lance E ^a  

^a ROYAL VETERINARY COLLEGE   (United Kingdom)

Author keywords

Adaptation; Mechanical loading; Micro computed tomography; Mouse; Parathyroid hormone

Indexed keywords

PARATHYROID HORMONE[1-34]; PARATHYROID HORMONE; PTH PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; BONE STRENGTH; BONE STRESS; BONE STRUCTURE; BONE TISSUE; C57BL 6 MOUSE; CHEMICAL LABELING; CONTROLLED STUDY; CORTICAL BONE; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG INTERMITTENT THERAPY; ENDOSTEUM; FEMALE; FLUORESCENCE ANALYSIS; HORMONE ACTION; MECHANICAL STRESS; MICRO-COMPUTED TOMOGRAPHY; MOUSE; NONHUMAN; PERIOSTEUM; TIBIA; TRABECULAR BONE; ULNA; ANIMAL; BONE; C57BL MOUSE; COMPUTER ASSISTED TOMOGRAPHY; CYTOLOGY; DRUG EFFECT; PHYSIOLOGY; TIME; WEIGHT BEARING;

ANIMALS; BONE AND BONES; FEMALE; MICE; MICE, INBRED C57BL; PARATHYROID HORMONE; TIBIA; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; ULNA; WEIGHT-BEARING;

EID: 52449085471     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2008.04.012     Document Type: Article

References (45)

1. Johnell O, Kanis JA. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int 2006;17:1726-33.
2. Sambrook P, Cooper C. Osteoporosis. Lancet 2006;367:2010-8.
3. Poole KE, Compston JE. Osteoporosis and its management. BMJ 2006;333:1251-6.
4. Canalis E, Giustina A, Bilezikian JP. Mechanisms of anabolic therapies for osteoporosis. N Engl J Med 2007;357:905-16.
5. Reeve J, Meunier PJ, Parsons JA, Bernat M, Bijvoet OL, Courpron P, et al. Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutional osteoporosis: a multicentre trial. Br Med J 1980;280:1340-4.
6. Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY, et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 2001;344:1434-41.
7. Reeve J. Recombinant human parathyroid hormone. BMJ 2002;324:435-6.
8. Cosman F, Nieves J, Zion M, Woelfert L, Luckey M, Lindsay R. Daily and cyclic parathyroid hormone in women receiving alendronate. N Engl J Med 2005;353:566-75.
9. Black DM, Bilezikian JP, Ensrud KE, Greenspan SL, Palermo L, Hue T, et al. One year of alendronate after one year of parathyroid hormone (1-84) for osteoporosis. N Engl J Med 2005;353:555-65.
10. Hodsman AB, Bauer DC, Dempster DW, Dian L, Hanley DA, Harris ST, et al. Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use. Endocr Rev 2005;26:688-703.
11. Burr DB. Does early PTH treatment compromise bone strength? The balance between remodeling, porosity, bone mineral, and bone size. Curr Osteoporos Rep 2005;3:19-24.
12. Cranney A, Papaioannou A, Zytaruk N, Hanley D, Adachi J, Goltzman D, et al. Parathyroid hormone for the treatment of osteoporosis: a systematic review. CMAJ 2006;175:52-9.
13. Tashjian Jr AH, Gagel RF. Teriparatide [human PTH(1-34)]: 2.5 years of experience on the use and safety of the drug for the treatment of osteoporosis. J Bone Miner Res 2006;21:354-65.
14. Greenspan SL, Bone HG, Ettinger MP, Hanley DA, Lindsay R, Zanchetta JR, et al. Effect of recombinant human parathyroid hormone (1-84) on vertebral fracture and bone mineral density in postmenopausal women with osteoporosis: a randomized trial. Ann Intern Med 2007;146:326-39.
15. Vestergaard P, Jorgensen NR, Mosekilde L, Schwarz P. Effects of parathyroid hormone alone or in combination with antiresorptive therapy on bone mineral density and fracture risk - a meta-analysis. Osteoporos Int 2007;18:45-57.
16. Halloran BP, Bikle DD, Harris J, Tanner S, Curren T, Morey-Holton E. Regional responsiveness of the tibia to intermittent administration of parathyroid hormone as affected by skeletal unloading. J Bone Miner Res 1997;12:1068-74.
17. Tanaka S, Sakai A, Tanaka M, Otomo H, Okimoto N, Sakata T, et al. Skeletal unloading alleviates the anabolic action of intermittent PTH(1-34) in mouse tibia in association with inhibition of PTH-induced increase in c-fos mRNA in bone marrow cells. J Bone Miner Res 2004;19:1813-20.
18. Turner RT, Lotinun S, Hefferan TE, Morey-Holton E. Disuse in adult male rats attenuates the bone anabolic response to a therapeutic dose of parathyroid hormone. J Appl Physiol 2006;101:881-6.
19. Robbins J, Aragaki AK, Kooperberg C, Watts N, Wactawski-Wende J, Jackson RD, et al. Factors associated with 5-year risk of hip fracture in postmenopausal women. JAMA 2007;298:2389-98.
20. Lanyon L, Armstrong V, Ong D, Zaman G, Price J. Is estrogen receptor alpha key to controlling bones' resistance to fracture? J Endocrinol 2004;182:183-91.
21. Skerry TM. One mechanostat or many? Modifications of the site-specific response of bone to mechanical loading by nature and nurture. J Musculoskelet Neuronal Interact 2006;6:122-7.
22. Rubin J, Rubin C, Jacobs CR. Molecular pathways mediating mechanical signaling in bone. Gene 2006;367:1-16.
23. Jee WS, Tian XY. The benefit of combining non-mechanical agents with mechanical loading: a perspective based on the Utah paradigm of skeletal physiology. J Musculoskelet Neuronal Interact 2005;5:110-8.
24. Lindsay R, Zhou H, Cosman F, Nieves J, Dempster DW, Hodsman AB. Effects of a one-month treatment with PTH(1-34) on bone formation on cancellous, endocortical, and periosteal surfaces of the human ilium. J Bone Miner Res 2007;22:495-502.
25. Compston JE. Skeletal actions of intermittent parathyroid hormone: effects on bone remodelling and structure. Bone 2007;40:1447-52.
26. Fox J, Miller MA, Newman MK, Recker RR, Turner CH, Smith SY. Effects of daily treatment with parathyroid hormone 1-84 for 16 months on density, architecture and biomechanical properties of cortical bone in adult ovariectomized rhesus monkeys. Bone 2007;41:321-30.
27. Sugiyama T, Yamaguchi A, Kawai S. Effects of skeletal loading on bone mass and compensation mechanism in bone: a new insight into the qmechanostatq theory. J Bone Miner Metab 2002;20:196-200.
28. Sugiyama T, Takaki T, Sakanaka K, Sadamaru H, Mori K, Kato Y, et al. Warfarin-induced impairment of cortical bonematerial quality and compensatory adaptation of cortical bone structure to mechanical stimuli. J Endocrinol 2007;194:213-22.
29. Carvalho RS, Scott JE, Suga DM, Yen EH. Stimulation of signal transduction pathways in osteoblasts by mechanical strain potentiated by parathyroid hormone. J Bone Miner Res 1994;9:999-1011.
30. Ryder KD, Duncan RL. Parathyroid hormone modulates the response of osteoblast-like cells to mechanical stimulation. Calcif Tissue Int 2000;67:241-6.
31. Capozza R, Ma YF, Ferretti JL, Meta M, Alippi R, Zanchetta J, et al. Tomographic (pQCT) and biomechanical effects of hPTH(1-38) on chronically immobilized or overloaded rat femurs. Bone 1995;17:233S-9S.
32. Chow JW, Fox S, Jagger CJ, Chambers TJ. Role for parathyroid hormone in mechanical responsiveness of rat bone. Am J Physiol 1998;274:E146-54.
33. Ma Y, Jee WS, Yuan Z, Wei W, Chen H, Pun S, et al. Parathyroid hormone and mechanical usage have a synergistic effect in rat tibial diaphyseal cortical bone. J Bone Miner Res 1999;14:439-48.
34. Hagino H, Okano T, Akhter MP, Enokida M, Teshima R. Effect of parathyroid hormone on cortical bone response to in vivo external loading of the rat tibia. J Bone Miner Metab 2001;19:244-50.
35. Li J, Duncan RL, Burr DB, Gattone VH, Turner CH. Parathyroid hormone enhances mechanically induced bone formation, possibly involving L-type voltage-sensitive calcium channels. Endocrinology 2003;144:1226-33.
36. Kim CH, Takai E, Zhou H, von Stechow D, Muller R, Dempster DW, et al. Trabecular bone response to mechanical and parathyroid hormone stimulation: the role of mechanical microenvironment. J Bone Miner Res 2003;18:2116-25.
37. Zhou H, Iida-Klein A, Lu SS, Ducayen-Knowles M, Levine LR, Dempster DW, et al. Anabolic action of parathyroid hormone on cortical and cancellous bone differs between axial and appendicular skeletal sites in mice. Bone 2003;32:513-20.
38. Davey RA, MacLean HE, McManus JF, Findlay DM, Zajac JD. Genetically modified animal models as tools for studying bone and mineral metabolism. J Bone Miner Res 2004;19:882-92.
39. Lau KH, Kapur S, Kesavan C, Baylink DJ. Up-regulation of the Wnt, estrogen receptor, insulin-like growth factor-I, and bone morphogenetic protein pathways in C57BL/6J osteoblasts as opposed to C3H/HeJ osteoblasts in part contributes to the differential anabolic response to fluid shear. J Biol Chem 2006;281:9576-88.
40. Lee KC, Maxwell A, Lanyon LE. Validation of a technique for studying functional adaptation of the mouse ulna in response to mechanical loading. Bone 2002;31:407-12.
41. De Souza RL, Matsuura M, Eckstein F, Rawlinson SC, Lanyon LE, Pitsillides AA. Noninvasive axial loading of mouse tibiae increases cortical bone formation and modifies trabecular organization: a new model to study cortical and cancellous compartments in a single loaded element. Bone 2005;37:810-8.
42. Baron R, Vignery A, Neff L, Silverglate A, Santa Maria A. Processing of undecalcified bone specimens for bone histomorphometry. In: Recker RR, editor. Bone histomorphometry: techniques and interpretation. Boca Raton: CRC Press; 1983. 13, 34.
43. Iida-Klein A, Zhou H, Lu SS, Levine LR, Ducayen-Knowles M, Dempster DW, et al. Anabolic action of parathyroid hormone is skeletal site specific at the tissue and cellular levels in mice. J Bone Miner Res 2002;17:808-16.
44. Iida-Klein A, Hughes C, Lu SS, Moreno A, Shen V, Dempster DW, et al. Effects of cyclic versus daily hPTH(1-34) regimens on bone strength in association with BMD, biochemical markers, and bone structure in mice. J Bone Miner Res 2006;21:274-82.
45. Frost HM. Bone's mechanostat: a 2003 update. Anat Rec A Discov Mol Cell Evol Biol 2003;275:1081-101.